We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On 12 August 2009, FDA published two rules that seek to clarify the methods available to seriously ill patients interested in gaining access to investigational drugs and biologics when they are not eligible to participate in a clinical trial and don’t have other satisfactory treatment options
The Center for Devices and Radiological Health (CDRH) has moved to the FDA White Oak Campus in Silver Spring, Maryland (located at 10903 New Hampshire Avenue, Silver Spring, MD 20993
